ASSESSING THE ASSOCIATION OF OMALIZUMAB USE AND ARTERIOTHROMBOTIC EVENTS THROUGH SPONTANEOUS ADVERSE EVENT REPORTING

被引：0
|
作者：
Ali, A. K. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.285
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A51 / A51
页数：1
相关论文
共 50 条
  • [1] Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting
    Ali, Ayad K.
    Hartzema, Abraham G.
    [J]. JOURNAL OF ASTHMA AND ALLERGY, 2012, 5 : 1 - 9
  • [2] Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
    Piccinni, Carlo
    Motola, Domenico
    Marchesini, Giulio
    Poluzzi, Elisabetta
    [J]. DIABETES CARE, 2011, 34 (06) : 1369 - 1371
  • [3] Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline
    Chedid, Victor
    Vijayvargiya, Priya
    Camilleri, Michael
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (03) : 336 - 338
  • [4] Adverse events and adverse event reporting systems
    Huebler, M.
    Moellemann, A.
    Metzler, H.
    Koch, T.
    [J]. ANAESTHESIST, 2007, 56 (10): : 1067 - +
  • [5] Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting
    Wang, Tiansheng
    Lu, Wenchao
    Li, Dandan
    Tang, Huilin
    Yang, Jeff Y.
    Buse, John B.
    Sturmer, Til
    [J]. DIABETES CARE, 2019, 42 (06) : E89 - E91
  • [6] Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting
    Li, Dandan
    Silvester, Jocelyn Anne
    Crowley, Matthew J.
    Yang, Jeff Y.
    Alexopoulos, Anastasia-Stefania
    Xu, Yang
    Zhan, Siyan
    Wang, Tiansheng
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2020, 11
  • [7] Standards for assessing and reporting adverse events
    Kawakami, Takashi
    Kohsaka, Shun
    Sato, Yasunori
    Fukuda, Keiichi
    Matsubara, Hiromi
    [J]. LANCET RESPIRATORY MEDICINE, 2022, 10 (12): : E110 - E111
  • [8] Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
    Wang, Tiansheng
    Lu, Wenchao
    Tang, Huilin
    Buse, John B.
    Sturmer, Til
    Gower, Emily W.
    [J]. DIABETES CARE, 2019, 42 (02) : E21 - E23
  • [9] Spontaneous reporting of rare events associated with atypical antipsychotics using the FDA adverse event reporting system
    Emechebe, Nnadozie
    Mukhtar, Fahad
    Scheer, Darren
    Patel, Arshiya
    Wadhawan, Abhishek
    Schwartz, Skai
    Zgibor, Janice
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 345 - 346
  • [10] Use of adverse events spontaneous reporting for drug safety surveillance in pregnancy
    Hsu, Wan-Ting
    Hernandez-Diaz, Sonia
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 360 - 360
12345